Bowman-Birk Inhibitor (BBI) protein from soy bean is a serine protease inhibitor of 71 amino acid residues containing seven disulphide bonds. It has two distinct 9 amino acid loops which inhibit α-chymotrypsin and trypsin, respectively. Chemical protein synthesis, using a divergent strategy, was used to prepare analogues of BBI to improve α-chymotrypsin inhibition. Four BBI analogues were prepared, and a four-fold improvement in chymotrypsin inhibition was obtained. Crystal structures of cocrystallised α-chymotrypsin:BBI complexes were determined for both wtBBI from soy bean and a synthetic 27L,42T,43F,45I,47P-BBI variant. The crystal structures confirmed the correct protein fold of the synthetic BBI and showed a similar overall structure to the wtBBI.
